Research Paper Volume 15, Issue 10 pp 4122—4143
PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest
Figure 5. Associations between PCNT expression level with mutation profile. (A) The waterfall plot presented the mutation difference of top 15 genes between high and low PCNT mRNA groups. (B) PCNT mRNA level positively correlated with TMB, MSI, HRD, and LOH, but negatively correlated with tumor purity. (C–J) The difference of TMB (C), MSI (D), tumor purity (E), HRD (F), MATH (G), tumor neoantigen (H), tumor ploidy (I), and LOH (J) between high and low PCNT expression groups.